NCT03748225 (FAMI-LIFE) is a clinical trial in Bereaved Families, sponsored by Hôpital Franco-Britannique-Fondation Cognacq-Jay.

Who is sponsoring NCT03748225?

NCT03748225 is sponsored by Hôpital Franco-Britannique-Fondation Cognacq-Jay.

What condition does NCT03748225 study?

NCT03748225 studies Bereaved Families.

Is NCT03748225 still recruiting?

NCT03748225 is currently completed. Last updated 11 February 2021.

Last reviewed 2021-02-11 · How we verify

NCT03748225: FAMI-LIFE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Incidence and Risk Factors of Prolonged Grief in Palliative Care Units

Completed Last updated 11 February 2021

What this trial tests

trial in Bereaved Families in 609 participants. Completed in 10 February 2021.

Timeline

4 February 2019

Primary endpoint
1 October 2020

10 February 2021

Quick facts

Lead sponsor	Hôpital Franco-Britannique-Fondation Cognacq-Jay
Status	Completed
Study type	OBSERVATIONAL
Enrollment	609
Start date	4 February 2019
Primary completion	1 October 2020
Estimated completion	10 February 2021
Sites	1 location across France

Conditions studied

Bereaved Families — all drugs for Bereaved Families →

Sponsor

Hôpital Franco-Britannique-Fondation Cognacq-Jay — full company profile →

Who can join

18 and older, any sex, with Bereaved Families. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the incidence and risk factors of prolonged grief in family members of patients died in French palliative care units and to explore experience of bereaved families to build a scientifically valid management prevention program.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Fami-life study: protocol of a prospective observational multicenter mixed study of psychological consequences of grieving relatives in French palliative care units on behalf of the family research in palliative care (F.R.I.P.C research network).
Garrouste-Orgeas M, Flahault C, Poulain E, Evin A, et al · · 2019 · cited 4× · PMID 31818281 · DOI 10.1186/s12904-019-0496-4

Verify or expand the search:

Other Hôpital Franco-Britannique-Fondation Cognacq-Jay trials

Trials by the same sponsor.

NCT04266002 — HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Therapy · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03748225 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hôpital Franco-Britannique-Fondation Cognacq-Jay
Last refreshed: 11 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03748225.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing